Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sphingosine-1-phosphate receptor 4 (S1PR4) is a G protein-coupled receptor that binds the lipid signaling molecule sphingosine-1-phosphate (S1P). It is primarily expressed on hematopoietic and lymphoid tissues, particularly immune cells like neutrophils and dendritic cells. S1PR4 plays a role in both innate and adaptive immunity, influencing cell proliferation, angiogenesis, migration, cytoskeleton organization, and immune cell trafficking. It couples primarily with Gi and G12/13 proteins, activating Rho kinase and influencing cytoskeletal rearrangement. Its selective expression on immune cells makes it a potential target for modulating immune responses, especially in autoimmune or inflammatory diseases.
Signals through Gi/G12/13 proteins; Modulates Rho kinase activity; Influences PTEN/Akt pathway
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sphingosine-1-phosphate receptor 4 (S1PR4).